TCL Archive Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible May 26, 1995
TCL Archive Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction” September 11, 1998
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: NCI May Support Studies Of Heat As Therapeutic Method DTIC OK Near for Malignant Melanoma May 16, 1975
